On October 3, I am honored to welcome Norman E. "Ned" Sharpless Medical Doctor, who served as Director of the National Cancer Institute (NCI) at the University of North Carolina.
In addition to serving as a director of NCI, Dr. Sharpless continued his work to understand the biology of the aging process and to promote the conversion of normal self-regenerating cells to dysfunctional cancer cells. Dr. Sharpless has made an important contribution to the understanding of the relationship between aging and cancer and the preclinical development of new treatments for melanoma, lung cancer, breast cancer.
During the visit to the UChicago Medical Comprehensive Cancer Center, he met with the leaders, teachers and students of the Comprehensive Cancer Center. He also hosted the afternoon seminars on NCI priorities and initiatives, and his research on cancer and aging.
Funding from NCI to organize our scientific research program to maximize cancer treatment
Last week, the National Institutes of Health (NCI) of the National Institute of Health (NIH) published an annual report on cancer status in 2018. At the opening meeting on 2nd June, NCI Director Norman E. Sharpless, MD highlighted the best news reported to the participants of the annual meeting. Nationality However, Dr. Sharpless also brought other good news: "We received strong and bipartisan support from the Congress on cancer research," the budget of NCI and NIH increased for 4 consecutive years Did. He said that the comprehensive budget passed by Congress provided growth of $ 275 million for the NCI budget this year and total funds for cancer Moonshot.
Research on cancer and other diseases is essential to our national interests and because of its high cost, the federal government progresses through the National Cancer Institute (NCI), a subsidiary of the National Institutes of Health (NIH) Medical research in Medicine is funded. In 2017 NCI's cancer research budget was about 5.8 billion dollars. We compete with NCI for financing through leading financing research universities and scientists from private research institutes - such as Harvard University, Souk Institute, Sloan Catechu Cancer Center, St. Jude Children's Research Hospital - a competitive peer review financing process. NCI guarantees that our cancer research agenda has focus, continuity, and considerable resources
Before getting detailed information on who will be the director of the National Institutes of Health (NIH) and the National Cancer Institute (NCI), how does the Trump regime react to cancer research, How is it based on needs? Cancer research takes precedence and the future of NCI's research funding is uncertain. The Department of Defense also plays a very important role in cancer warfare. The Department of Defense has a program called Congressional Medicine Research Program (CDMRP), which has about 24 cancer research programs. One of the plans is the prostate cancer program, which is $ 80 million.